Kraig Biocraft Laboratories Opens New Production Center
Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) has made a significant advancement in its production capabilities with the completion of a new, larger production center. This facility is specifically designed for the advanced manufacturing of spider silk, representing a key milestone in the company's operational strategy.
Strategic Growth in Production Capacity
Following the successful results from its spring production trials, Kraig Labs developed a plan to quickly scale up its production capacity. This plan was executed in two phases. The first phase was completed earlier and ensured the company had sufficient operational space during challenging seasonal conditions.
Groundbreaking of the New Facility
The groundbreaking for the new production center occurred in July. This facility is set to enhance the company's spider silk rearing capacity by over eight times. With dedicated areas for each BAM-1 parental line and a specialized hatchery for BAM-1 hybrids, this development positions the company to meet its production objectives in the coming year.
Transitioning to the New Center
Currently, the company is transitioning its production operations to this expansive new center. This process includes relocating essential equipment and upgrading power generation capabilities to ensure uninterrupted production. The next production cycle is expected to begin shortly, which will strategically position the company to meet its operational needs.
Largest Production Cycle in Company History
The first production cycle at the new facility is set to be the largest single-cycle rearing of BAM-1 strains to date. This maximizes the use of the newly acquired space, allowing for a more efficient output that the company has been preparing for.
Advantages of the New Production Center
Jon Rice, the Chief Operating Officer of Kraig Labs, expressed excitement about the operational opportunities the new facility presents. He noted that this expansion aligns seamlessly with their fall production initiatives, enabling the company to enhance its output through improved silk manufacturing infrastructure.
A Groundbreaking Step in Spider Silk Production
This new facility underscores Kraig Labs' ongoing dedication to pioneering advancements in spider silk technology. By increasing production capacity, the company is laying a strong foundation to meet the growing market demands in the textile industry.
About Kraig Biocraft Laboratories
Kraig Biocraft Laboratories, Inc. is recognized as a leading innovator in genetically engineered spider silk-based fiber technologies. The company has made significant scientific advancements in spider silk technology, which promises to transform applications within the global textile sector. For the latest updates on Kraig Biocraft Laboratories and its innovative projects, it is advisable to keep an eye on the company's communications.
Frequently Asked Questions
What is the purpose of the new production center?
The new production center is designed to greatly enhance Kraig Labs' capacity for spider silk manufacturing, facilitating more efficient and larger-scale production.
How much has production capacity increased?
The new facility boosts production capacity by more than eight times compared to previous operations.
When does the next production cycle begin?
The next production cycle is expected to start at the end of this month.
What are BAM-1 parental strains?
BAM-1 parental strains refer to specific lines of genetically modified silkworms utilized in the production of spider silk by Kraig Labs.
How can I stay updated on Kraig Labs' news?
You can follow Kraig Labs through their website to receive the latest updates and news regarding their innovations and production efforts.
